This preclinical study investigated the therapeutic effects of BPC 157, a stable gastric pentadecapeptide, in rat models of colitis and ischemia-reperfusion injury. BPC 157 administration led to significant improvements in mucosal healing, reduction of inflammatory markers, and restoration of vascular integrity. The peptide modulated the nitric oxide (NO) system, counteracting
